These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30316795)

  • 1. TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma.
    Jin Q; Li H; Jin Z; Huang L; Wang F; Zhou Y; Liu Y; Jiang C; Oswald J; Wu J; Song X
    Int J Pharm; 2018 Dec; 553(1-2):21-28. PubMed ID: 30316795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes as a Novel Ocular Delivery System for Brinzolamide: In Vitro and In Vivo Studies.
    Li H; Liu Y; Zhang Y; Fang D; Xu B; Zhang L; Chen T; Ren K; Nie Y; Yao S; Song X
    AAPS PharmSciTech; 2016 Jun; 17(3):710-7. PubMed ID: 26335415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy.
    Li T; Wang Y; Chen J; Gao X; Pan S; Su Y; Zhou X
    Drug Deliv; 2020 Dec; 27(1):410-421. PubMed ID: 32133894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation.
    Wu W; Li J; Wu L; Wang B; Wang Z; Xu Q; Xin H
    AAPS PharmSciTech; 2013 Sep; 14(3):1063-71. PubMed ID: 23813437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brinzolamide loaded core-shell nanoparticles for enhanced coronial penetration in the treatment of glaucoma.
    Song J; Zhang Z
    J Appl Biomater Funct Mater; 2020; 18():2280800020942712. PubMed ID: 33151769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revamping the corneal permeability and antiglaucoma therapeutic potential of brinzolamide using transniosomes: optimization,
    Patil RK; Srivastava V; Bhawale R; Tryphena KP; Khatri DK; Doijad N; Mehra NK
    Nanomedicine (Lond); 2024; 19(11):947-964. PubMed ID: 38483291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of inclusion complex of brinzolamide with hydroxypropyl-β-cyclodextrin.
    Zhang Y; Ren K; He Z; Li H; Chen T; Lei Y; Xia S; He G; Xie Y; Zheng Y; Song X
    Carbohydr Polym; 2013 Oct; 98(1):638-43. PubMed ID: 23987393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dorzolamide-loaded PLGA/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits.
    Warsi MH; Anwar M; Garg V; Jain GK; Talegaonkar S; Ahmad FJ; Khar RK
    Colloids Surf B Biointerfaces; 2014 Oct; 122():423-431. PubMed ID: 25159319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
    Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
    Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery.
    Shrivastava N; Khan S; Baboota S; Ali J
    Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study.
    Dubey V; Mohan P; Dangi JS; Kesavan K
    Int J Biol Macromol; 2020 Jun; 152():1224-1232. PubMed ID: 31751741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation.
    Sun J; Zhou Z
    Drug Des Devel Ther; 2018; 12():383-389. PubMed ID: 29503531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cubosome based system for ocular delivery of acetazolamide.
    Teba HE; Khalil IA; El Sorogy HM
    Drug Deliv; 2021 Dec; 28(1):2177-2186. PubMed ID: 34662264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical overview of brinzolamide.
    DeSantis L
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S119-29. PubMed ID: 10665514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipid Free Nano-Vesicles of Brinzolamide Biopolymer Ocular Insert; Design, In vitro and In vivo Evaluation.
    Hady MA; El-Zahaby SA
    J Pharm Sci; 2024 Aug; 113(8):2178-2187. PubMed ID: 38428457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoliposome-Encapsulated Brinzolamide-hydropropyl-β-cyclodextrin Inclusion Complex: A Potential Therapeutic Ocular Drug-Delivery System.
    Wang F; Bao X; Fang A; Li H; Zhou Y; Liu Y; Jiang C; Wu J; Song X
    Front Pharmacol; 2018; 9():91. PubMed ID: 29487529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma.
    Salama HA; Ghorab M; Mahmoud AA; Abdel Hady M
    AAPS PharmSciTech; 2017 Oct; 18(7):2517-2528. PubMed ID: 28224390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma.
    Sharma PK; Chauhan MK
    Curr Eye Res; 2021 Nov; 46(11):1703-1716. PubMed ID: 33844617
    [No Abstract]   [Full Text] [Related]  

  • 19. Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation.
    Bhalerao H; Koteshwara KB; Chandran S
    AAPS PharmSciTech; 2020 Jan; 21(2):69. PubMed ID: 31950311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests.
    Mahboobian MM; Seyfoddin A; Aboofazeli R; Foroutan SM; Rupenthal ID
    Pharm Dev Technol; 2019 Jun; 24(5):600-606. PubMed ID: 30472913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.